Marco Taglietti
CIK 1408870 · Chief Executive Officer · last filed 2026-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$192.8K
Companies
5
Total Filings
74
Lifetime Open-Market Net
$1.57M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AQST | Director | — | $3.76 | — | $0 | 7 | 2026-06-12 |
| SCYX | Chief Executive Officer | 34,008 | $3.63 | $123.4K | $2.13M | 35 | 2022-04-28 |
| DCTH | Director | 6,001 | $11.55 | $69.3K | $106.8K | 6 | 2020-05-08 |
| NephroGenex, Inc. (NRX) Delisted | Director | — | — | — | $0 | 2 | 2015-05-04 |
| Forest Laboratories, LLC (FRX) Delisted | EVP-Drug Dev & Ch.Medical Off. | 100,486 | $12.00 | $1.21M | -$663.9K | 23 | 2013-12-10 |
Recent Filings · Page 2 of 8
74 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-12-23 | SCYX | Mixed | +40,000 | $250.0K | EDGAR |
| 2020-05-08 | DCTH | Conv (C) | +6,000 | $0 | EDGAR |
| 2020-02-04 | SCYX | Grant (A) | — | $0 | EDGAR |
| 2019-12-16 | SCYX | Buy (P) | +166,667 | $150.0K | EDGAR |
| 2019-08-22 | SCYX | Buy (P) | +10,000 | $11.1K | EDGAR |
| 2019-08-19 | SCYX | Buy (P) | +10,015 | $10.1K | EDGAR |
| 2019-07-26 | DCTH | Buy (P) | — | $0 | EDGAR |
| 2019-04-18 | SCYX | Buy (P) | +25,000 | $40.8K | EDGAR |
| 2019-02-19 | SCYX | Grant (A) | — | $0 | EDGAR |
| 2019-02-05 | DCTH | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.